Find an Eye MD near you!

The FDA has approved Zeimer’s femtosecond laser device.

Shire announced that lifitegrast met its primary and secondary endpoints

Investigators found that the latest concept in the prevention of post-cataract posterior capsule opacification appears promising.

Adherence patterns established during the first year of treatment typically don’t change over time.

University of Leeds researcher is developing an IOL for presbyopia made from liquid crystal.